FDA Approves Bemotrizinol — the First New Sunscreen Filter in 20 Years
The FDA approved bemotrizinol, the first new sunscreen active ingredient in the U.S. in about 20 years — a broad-spectrum UVA/UVB filter usable from August 9, 2026.
TL;DR — The FDA approved bemotrizinol (BEMT), the first new sunscreen active ingredient in the U.S. in about 20 years — a broad-spectrum UVA/UVB filter already used abroad for ~27 years — with manufacturers able to use it from August 9, 2026.
For the first time in roughly two decades, Americans are getting a new sunscreen ingredient. On June 9, 2026, the FDA approved bemotrizinol.
The approval
The FDA issued a final administrative order determining bemotrizinol (BEMT) generally recognized as safe and effective for sunscreen use in ages 6 months and older — the first new U.S. sunscreen active ingredient in about 20 years. The broad-spectrum chemical filter absorbs both UVA and UVB, has been used in Europe and elsewhere for roughly 27 years, and data show it does not meaningfully enter the bloodstream. Manufacturers can begin using it on August 9, 2026.
| Detail | |
|---|---|
| Ingredient | Bemotrizinol (BEMT) |
| Protection | Broad-spectrum UVA + UVB |
| First new U.S. filter in | ~20 years |
| Usable from | Aug 9, 2026 |
What they said
"The agency has historically moved too slowly in this area, leaving Americans with fewer options than consumers abroad." — Dr. Marty Makary, FDA Commissioner
Why it matters
- The U.S. catches up. Europe and Asia have had more modern filters for decades.
- Better UVA protection. A new broad-spectrum option expands formulation choices.
- Modernizing OTC rules. It signals a faster FDA approach to sunscreen ingredients.
FAQ
What is bemotrizinol?
Bemotrizinol (BEMT) is a broad-spectrum chemical sunscreen filter that absorbs both UVA and UVB light. On June 9, 2026 the FDA deemed it safe and effective for ages 6 months and up — the first new U.S. sunscreen active ingredient in about 20 years.
When will sunscreens with bemotrizinol be available?
Manufacturers can begin using bemotrizinol on August 9, 2026, with products expected on U.S. shelves later in 2026. The ingredient has already been used in Europe and elsewhere for roughly 27 years.
Sources
Image: U.S. FDA logo by U.S. Food and Drug Administration — Public domain, via Wikimedia Commons.
← Back to all posts